289 related articles for article (PubMed ID: 15469410)
1. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.
Solus JF; Arietta BJ; Harris JR; Sexton DP; Steward JQ; McMunn C; Ihrie P; Mehall JM; Edwards TL; Dawson EP
Pharmacogenomics; 2004 Oct; 5(7):895-931. PubMed ID: 15469410
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation of cytochrome P450 in Uyghur Chinese population.
Qi G; Li D; Zhang X
Drug Metab Pharmacokinet; 2018 Feb; 33(1):55-60. PubMed ID: 29233455
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.
Yokoi T; Kamataki T
Pharm Res; 1998 Apr; 15(4):517-24. PubMed ID: 9587945
[TBL] [Abstract][Full Text] [Related]
4. In vitro assessment of the allelic variants of cytochrome P450.
Hiratsuka M
Drug Metab Pharmacokinet; 2012; 27(1):68-84. PubMed ID: 22041138
[TBL] [Abstract][Full Text] [Related]
5. CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South-East and East Asian populations: A systematic review.
Dorji PW; Tshering G; Na-Bangchang K
J Clin Pharm Ther; 2019 Aug; 44(4):508-524. PubMed ID: 30980418
[TBL] [Abstract][Full Text] [Related]
6. Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects.
Matimba A; Del-Favero J; Van Broeckhoven C; Masimirembwa C
Hum Genomics; 2009 Jan; 3(2):169-90. PubMed ID: 19164093
[TBL] [Abstract][Full Text] [Related]
7. Genetic contribution to variable human CYP3A-mediated metabolism.
Lamba JK; Lin YS; Schuetz EG; Thummel KE
Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
[TBL] [Abstract][Full Text] [Related]
8. PM frequencies of major CYPs in Asians and Caucasians.
Mizutani T
Drug Metab Rev; 2003; 35(2-3):99-106. PubMed ID: 12959412
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.
Veiga MI; Asimus S; Ferreira PE; Martins JP; Cavaco I; Ribeiro V; Hai TN; Petzold MG; Björkman A; Ashton M; Gil JP
Eur J Clin Pharmacol; 2009 Apr; 65(4):355-63. PubMed ID: 18979093
[TBL] [Abstract][Full Text] [Related]
10. Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms.
Smart J; Daly AK
Pharmacogenetics; 2000 Feb; 10(1):11-24. PubMed ID: 10739168
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.
Dandara C; Lombard Z; Du Plooy I; McLellan T; Norris SA; Ramsay M
Pharmacogenomics; 2011 Dec; 12(12):1663-70. PubMed ID: 22118051
[TBL] [Abstract][Full Text] [Related]
12. Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.
Bertilsson L
Clin Pharmacokinet; 1995 Sep; 29(3):192-209. PubMed ID: 8521680
[TBL] [Abstract][Full Text] [Related]
13. Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes.
Makeeva O; Stepanov V; Puzyrev V; Goldstein DB; Grossman I
Pharmacogenomics; 2008 Jul; 9(7):847-68. PubMed ID: 18597650
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
Zuo J; Xia D; Jia L; Guo T
Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
16. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.
Suarez-Kurtz G; Genro JP; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Ribeiro-dos-Santos A; Romano-Silva MA; Santana I; Struchiner CJ
Pharmacogenomics J; 2012 Jun; 12(3):267-76. PubMed ID: 21173785
[TBL] [Abstract][Full Text] [Related]
17. Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population.
Wang HH; Liao YW; Chiang HL; Wu JY; Chen YT
Pharmacogenomics; 2009 Mar; 10(3):359-74. PubMed ID: 19290787
[TBL] [Abstract][Full Text] [Related]
18. Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes.
Gao N; Tian X; Fang Y; Zhou J; Zhang H; Wen Q; Jia L; Gao J; Sun B; Wei J; Zhang Y; Cui M; Qiao H
Eur J Pharm Sci; 2016 Sep; 92():86-97. PubMed ID: 27339126
[TBL] [Abstract][Full Text] [Related]
19. African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.
Rajman I; Knapp L; Morgan T; Masimirembwa C
EBioMedicine; 2017 Mar; 17():67-74. PubMed ID: 28237373
[TBL] [Abstract][Full Text] [Related]
20. Allele frequency differences of cytochrome P450 polymorphisms in a sample of New Zealand Māori.
Lea RA; Roberts RL; Green MR; Kennedy MA; Chambers GK
N Z Med J; 2008 Apr; 121(1272):33-7. PubMed ID: 18425152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
